186 related articles for article (PubMed ID: 27640244)
1. A comparison between conventional liposome and drug-cyclodextrin complex in liposome system.
Wang WX; Feng SS; Zheng CH
Int J Pharm; 2016 Nov; 513(1-2):387-392. PubMed ID: 27640244
[TBL] [Abstract][Full Text] [Related]
2. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
3. Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen.
Zhang L; Zhang Q; Wang X; Zhang W; Lin C; Chen F; Yang X; Pan W
Int J Pharm; 2015 Aug; 492(1-2):40-5. PubMed ID: 26162980
[TBL] [Abstract][Full Text] [Related]
4. Preparation of drug-in-cyclodextrin-in-liposomes at a large scale using a membrane contactor: Application to trans-anethole.
Gharib R; Greige-Gerges H; Jraij A; Auezova L; Charcosset C
Carbohydr Polym; 2016 Dec; 154():276-86. PubMed ID: 27577919
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
7. Thirty years with cyclodextrins.
Duchêne D; Bochot A
Int J Pharm; 2016 Nov; 514(1):58-72. PubMed ID: 27863683
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
Nekkanti V; Rueda J; Wang Z; Betageri GV
Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
[TBL] [Abstract][Full Text] [Related]
10. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome.
Gillet A; Grammenos A; Compère P; Evrard B; Piel G
Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972
[TBL] [Abstract][Full Text] [Related]
11. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.
Piel G; Piette M; Barillaro V; Castagne D; Evrard B; Delattre L
Int J Pharm; 2006 Apr; 312(1-2):75-82. PubMed ID: 16455215
[TBL] [Abstract][Full Text] [Related]
12. QbD based development of proliposome of lopinavir for improved oral bioavailability.
Patel GM; Shelat PK; Lalwani AN
Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
[TBL] [Abstract][Full Text] [Related]
13. Development of risperidone liposomes for brain targeting through intranasal route.
Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Characterization of Liposomes Double-loaded with Amphotericin B and Amphotericin B/hydroxypropyl-beta-cyclodextrin Inclusion Complex.
Tran THY; Vu TTG; Pham TMH
Pharm Nanotechnol; 2021; 9(3):236-244. PubMed ID: 33745428
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes.
Nkanga CI; Krause RW; Noundou XS; Walker RB
Int J Pharm; 2017 Jun; 526(1-2):466-473. PubMed ID: 28461265
[TBL] [Abstract][Full Text] [Related]
16. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study.
Matloob AH; Mourtas S; Klepetsanis P; Antimisiaris SG
Int J Pharm; 2014 Dec; 476(1-2):108-15. PubMed ID: 25269006
[TBL] [Abstract][Full Text] [Related]
17. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
[TBL] [Abstract][Full Text] [Related]
18. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.
Wang X; Guan Q; Chen W; Hu X; Li L
Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217
[TBL] [Abstract][Full Text] [Related]
19. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems.
Dalmoro A; Bochicchio S; Nasibullin SF; Bertoncin P; Lamberti G; Barba AA; Moustafine RI
Eur J Pharm Sci; 2018 Aug; 121():16-28. PubMed ID: 29777855
[TBL] [Abstract][Full Text] [Related]
20. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM
Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
